mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
1 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.003 |
1 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |